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Epidemiology of thyroid cancer in Ukraine after Chernobyl
Thyroid malignancies are relatively rare worldwide, yet their incidence has increased 
over the last few decades [1,2]. Epidemiology of thyroid cancer in the population of Ukraine 
exposed to radiation as a result of accident at the Chernobyl Nuclear Power Plant in April, 
1986 is of a particular interest. Although the relationship between the Chernobyl radiation 
and increasing incidence of thyroid cancer among exposed children and adolescents in 
Belarus, Russia, and Ukraine is established in a number of studies and is the main proven 
health consequence of the accident [3,4], a continued monitoring and analysis of temporal 
trends of this disease have important medical and scientific impacts [5-7]. 
The purpose of this Chapter is to overview data on thyroid cancer incidence for the 
period from 1986 to 2010 in specific groups of population of Ukraine exposed in childhood 
or adolescence and also prenatally (in utero). In addition, the group of subjects born after 
the accident is included in the study because it provides important information on thyroid 
cancer incidence in the population of Ukraine which had not experienced Chernobyl fallouts. 
A tool for recording and storage of data on the incidence of any cancer are population-
based registries [8-11]; information can be used for subsequent analysis of morbidity and 
mortality in certain age groups and geographical areas. Domestic sources of data on thyroid 
cancer incidence in Ukraine are the site-specific Clinico-morphological Registry (CMR) of 
the State Institution “VP Komisarenko Institute of Endocrinology and Metabolism of the 
National Academy of Medical Sciences of Ukraine” (IEM) [12], and a classic cancer registry, 
which keeps records on all types of cancer, The National Cancer Registry of Ukraine (NCR) 
of the National Cancer Institute of the Ukraine Ministry of Public Health [13,14]. 
Specialized Clinico-morphological and National Cancer Registries of Ukraine 
In the first half of the 1980-ies there were no personalized records of thyroid cancer cases 
in Ukraine [15]. Statistical summary of thyroid cancer could be derived from the archives 
of hospitals or from the reports of regional endocrinology services. After the Chernobyl 
accident in 1986, the Ministry of Public Health of USSR recommended to establish 
personalized registries of affected population and to improve recording system of patients 
with thyroid diseases which were anticipated to be one of the possible health effects of the 
Chernobyl accident [16,17]. In Ukraine, the collection of data on thyroid cancer incidence 
Chapter3
Epidemiology of thyroid cancer in Ukraine  
after Chernobyl




was coordinated by the Institute of Endocrinology and Metabolism (IEM) with participation 
of regional endocrinology services.
In 1992, a personalized Clinico-morphological Registry was established at the IEM for 
the first time in Ukraine, into which all cases of thyroid cancer in patients whose age at the 
time of accident did not exceed 18 years (i.e., born in 1968 and later) were entered. Creation 
of the Registry was promoted by the initiative of the Ukraine Ministry of Public Health in 
the Order No. 12 dated January 20, 1992 “On the improvement of endocrinological care 
to children and adults with thyroid diseases” in which the need for an increased attention 
to thyroid disorders after the Chernobyl accident and compulsory referral of children 
and adolescents with such diseases for surgical treatment to the Clinic of the IEM was 
formally stated. In addition, regional and municipal endocrinology and oncology clinics 
were imposed to collect and report complete information about thyroid cancer cases in 
corresponding age group to IEM, and to provide histological slides of tumors for additional 
expertise of the quality of pathomorphological diagnosis. Thus, IEM managed to collect 
the necessary data for comprehensive registry functioning. 
In the post-Chernobyl period, the CMR has been continuously providing statistics on the 
number of cases and incidence of thyroid cancer among children and adolescents to the 
Ministry of Public Health and Academy of Medical Sciences of Ukraine, and also served as a 
source of data for a number of analytical studies on thyroid cancer incidence and assessment 
of radiation risks of thyroid cancer in the younger age groups of Ukraine [3,5,6,12].
 Statistical records of thyroid cancer as of a separate entity in the structure of oncological 
services of Ukraine were started in 1989 [14,18]. At the same time, the Institute of Oncology 
of the Academy of Medical Sciences of Ukraine launched an automated National Cancer 
Registry (NCR) that covered all regions of Ukraine. NCR was based on a network of specialized 
cancer institutions and a State system of cancer registration. Practical realization and 
implementation of the information system in oncology at the regional level began in the 
mid-’90-s receiving governmental support according to the Order of the Ukraine Ministry 
of Public Health “On the establishment of a National Cancer Registry of Ukraine” dated 
December 30, 1996 [14]. In 2001, the creation of the system was completed by including all 
regions of Ukraine in the Registry [13,14].
A close cooperation between the CMR and NCR began in 2005. Today, the CMR is in 
some way a part of NCR [19-21]. Note however, that cross-check of the registries reveals 
some discordances. The CMR is a specialized Clinico-morphological Registry that includes 
particular age group (at high risk for developing thyroid cancer) and only operated cases 
with pathologically confirmed diagnosis. In contrast, besides the CMR records, National 
Cancer Registry also includes cases that had not been operated with only preoperative 
cytological conclusion about the possibility of thyroid cancer available. Moreover, the 
calculation of cases at the regional level in the CMR is based on the patient’s place of 
residence at the time of Chernobyl accident, while the NCR system is based on the patient’s 
place of residence at surgery. In other words, these differences should always be taken into 
account when comparing the two data Registries or analyzing the incidence according to 
data of one or another registry. 
Pathological verification of diagnosis is essential for the case to be included in the CMR. 
The detailed pathological report including tumor type, subtype, invasive properties and 
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tumor size is mandatory  for cases operated at the Department of Surgery of Endocrine 
Glands of the IEM, and for the material (paraffin blocks, histological specimens) from 
patients operated elsewhere in Ukraine yet receiving radioactive iodine therapy at the 
Department of Clinical Radiology of the IEM (see Chapter 4).
Sources of information for the CMR are currently the reports of regional endocrinology 
services, data of regional oncological institutions (via the NCR of Ukraine), and clinical 
medical information system (MIS) of the IEM (www.therdep.com.ua). The principles of 
inclusion and recording of personal data coming from different sources correspond to 
the classical rules and procedures of cancer registries [22-24]. Automated procedures and 
control of completeness and quality of personal data play an important role [25]. 
 Software realization of Clinico-morphological Registry 
Entering and storage of Registry data is implemented using MS SQL Server software. 
This
 • ensures data integrity; 
 • allows the use of a standard relational model for designing data structures and typical 
SQL for queries; 
 • provides a reliable import/export of data from most databases; 
 • allows performing application tasks using typical software tools (MS Access, Delphi, 
C + +, *. net , etc.). 
The upgraded structure of registry databases provides some additional features: 
 • supports both Ukrainian and Russian versions of patient’s surname and first name; 
 • implements a mechanism of saving changes or multiple patient’s attributes’ values  (e.g. 
name, location, diagnosis); 
 • formalizes the place of residence according to the standard administrative territorial 
codifier “KOATO”. 
 
In addition, links have been established with databases with the geographical 
component at the regional, district and settlement level (MapInfo format), which extend 
the capabilities of data analysis and allow building various thematic maps. Today, the logical 
structure of the Registry includes three functional components: CaseRegist, CaseManager, 
and CaseReport. 
 • CaseRegist is a module of primary registration of data reported by the regional 
endocrinologists and IEM patients. 
 • CaseManager is a module of analysis, linkage, and verification of the Registry information. 
With this component, a comparative analysis of information from multiple sources 
is conducted including the search for and removal of duplicate records. A verified 
analytical version of the Registry record is generated that remains active for the year. 
A list of problematic cases to be verified by an expert morphologist and/or refined 
through queries to regional services could be created. The module also stores archives 
of the versions of analytical tables of the Registry from previous years; information about 
changes or refining of certain attributes of patients to be included in the next version of 
the Registry is accumulated. 
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 • CaseReport component contains the current version of analytical tables of the Registry 
and a set of typical queries to generate standard numerical tables, charts and graphs 
that describe the available data for particular time and can be used for the preparation 
of reports, presentations, and publications.
 The demographic component of the Clinico-morphological Registry 
The demographic component of the Registry is based on a series of periodic publications 
of the State Statistics Committee of Ukraine; publications of regional statistics departments 
may be also involved detailing certain parameters for a specific region. 
Census data represent the most reliable and detailed source of information on Ukrainian 
population. Our study period (from 1986 to 2010) includes two censuses: Ukrainian SSR 
census of 1989 and the All-Ukrainian census of 2001 [26, 27]. 
Primary sources of demographic data also include publications on the distribution of 
population by age and sex [28-33], the number of current and permanent population of 
Ukraine at the regional level, and annual demographic data records. 
General statistical collections and the official website of the State Statistics Committee 
(www.ukrstat.gov.ua) [34] may also be used as sources of current demographic information. 
The demographic component of the Registry includes data on the population of Ukraine 
for the period 1986 to 2010, and the following age groups are selected for monitoring: 
 • children under 14 years old (born before 1987);
 • children under 14 years old (born in 1987 or later);
 • adolescents aged 15 to 18 years (born before 1987);
 • adolescents aged 15 to 18 years (born in 1987 or later);
 • adults aged over 19 years (born before 1987, beginning from 1968);
 • adults aged over 19 years (born in 1987 or later);
 • in utero cohort (born from April 27 to December 31, 1986). 
Population in the Registry (i.e., population size for which cases are registered) is growing 
from year to year: while for the first year of study (1986) it was slightly less than 14 million 
people, in 2010 it includes over 26 million subjects. 
The demographic base of the Registry by attained age and ratio between exposed and 
unexposed subjects varies from year to year. The proportion of children and adolescents is 
monotonically decreasing (only that of born after Chernobyl remain practically unchanged), 
while the proportion of adults in the Registry is increasing (including those born both 
before and after Chernobyl). 
The demographic base of the Registry allows assessing: 
 • annual dynamics of the age group from 0 to 14 years (born before and after Chernobyl 
separately); 
 • annual dynamics of the age group from 15 to 18 years (born before and after Chernobyl 
separately);
 • annual dynamics of the age group over 19 years who were aged from 0 to 18 years at 
the time of the accident or born after Chernobyl; 
 • annual dynamics in the in utero cohort. 
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Since the size of groups in each region and in the whole of Ukraine is known, it is possible 
to make arbitrary combinations of regions and to compare the indices for the regions with 
the Ukraine as a whole.
To calculate the incidence, the most adequate determination of the number of person-
years in a given cohort for a particular year is to use the average population size. It should 
be taken into account that we are not dealing with an exact number but with estimates 
characterized by some uncertainty. Some worsening of the quality of demographic 
estimates by the end of the study period (1986-2010) could be expected due to 
postponement of the next census of Ukraine to 2014 or later. A very informative overview 
of the problems of quality of demographic data, uncertainties in population parameters, 
and possible problems of their interpretation was recently published [35]. 
Methodology of descriptive analysis of the incidence
Current analysis of thyroid cancer incidence in younger age groups of the population 
of Ukraine represents methodologically, in general, a continuation of a series of previous 
publications [36-41]. By age at the time of accident and conditions of exposure, the study 
subjects are divided into the following three groups: 
 • exposed as children, aged 0-14 years at the time of accident (0-14 AE);
 • exposed as adolescents, aged 15-18 years at the time of accident (15-18 AE);
 • exposed in utero, born in May-December 1986 (EIU).
The first group (0-14 AE) is the largest and includes about 11.2 million subjects; the 
second group (15-18 AE) about 2.2 million persons, and the size of the cohort exposed 
prenatally is estimated to be about 0.52 million. It should be noted that, according to the 
conditions of CMR establishment, registered population includes those born beginning 
from December 1, 1968, i.e. actually the second group includes the subjects aged from 15 
to <18.32 years at exposure (the population aged 18.32-18.99 belongs to the age cohort 
born in 1967). 
Subdivision of population into these three groups, besides general medical 
considerations, has dosimetric rationale as well. Radiation doses to the thyroid have strong 
age dependency [42-46]. Under similar radioecological conditions, the maximal radiation 
dose is received by the population of younger age. For regional estimates of mean radiation 
dose [43], the relative exposure dose (normalized to the dose in adults) for children aged 
one year is 4.5-6; for children aged 5 years – 3-4; for children aged 10 years – 1.7-2; and for 
children aged 14 – about 1.5. 
Similar age relationships are also inherent to risk coefficients (ERRD, EARD) of developing 
radiogenic cancer per exposure unit [4,47]. These patterns, taken together, indicate the 
highest expected radiogenic effects in the younger age groups of 0-4 years old and 5-9 
years old compared with those aged 10 years and older. 
Effects of thyroid exposure in utero are markedly different from those of postnatal 
irradiation, and information on risks is very limited [4,48,49]. 
The group born from 1987 was also used in later analyses as a control because it was not 
exposed to Chernobyl fallout and therefore does not include Chernobyl radiogenic cancers. 
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For the analysis by age at diagnosis, cases are subdivided into those diagnosed in 
children (aged 0-14 years at diagnosis), adolescents (aged 15-18 years at diagnosis), and 
adults (aged ≥19 years at diagnosis). Such subdivision is traditional for oncoepidemiology 
that recons childhood cancers a particular category [50,51]. A relatively new trend is to 
consider the group of adolescents and young adults (AYA) as patients requiring specific, 
tailored diagnostic procedures and streamlined procedures for cancer treatment [51-53]. 
Current analysis used a partition of 28 regions of Ukraine into two groups according to 
the level of thyroid exposure in children and adolescents [44,45, Chapter 2]: 
 • 6 most contaminated regions (Zhytomyr, Kyiv, Rivne, Chernihiv, Cherkasy regions and 
Kyiv City; average thyroid exposure dose in the group 0-18 years old at the time of the 
accident >35 mGy);
 • 21 regions with relatively lower levels of contamination (average thyroid exposure dose 
in the group 0-18 years old <35 mGy).
Childhood and adolescent population of the 6 most contaminated regions accounted 
for 19-20% of the total population of corresponding age of Ukraine (Tables 3.1 and 3.2). It 
should be stressed that Zhytomyr, Kyiv, and Chernihiv regions are located at a distance up 
to 200 km from Chernobyl Nuclear Power Plant; the residents of northern areas of these 
regions received the highest thyroid doses [3,54]. 
Table 3.1 
Thyroid cancer cases in selected groups of Ukrainian population in 1986-2010 















0-14 years at 
exposure 11.1 59 383 827 1221 2554 5044
6 regions 2.2 15 191 384 574 1019 2183
21 regions 8.9 44 192 443 647 1535 2861
15-18 years at 
exposure 2.2 45 162 291 411 733 1642
6 regions 0.4 9 41 89 156 269 564
21 regions 1.8 36 121 202 255 464 1078
Subjects exposed 
in utero 0.5 0 3 5 26 78 112
6 regions 0.1 0 1 2 9 32 44
21 regions 0.4 0 2 3 17 46 68
Subjects born in 
1987 and later 12.0 
b 0 0 11 103 392 506
6 regions 2.5 b 0 0 3 32 123 158
21 regions 9.5 b 0 0 8 71 269 348
Total cases 104 548 1134 1761 3757 7304
a - exposed population on 1 January 1987; b - estimation of unexposed population on 1 January 2011 
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Table 3.2 
Thyroid cancer cases in selected groups of Ukrainian population in 1986-2010
(by age at surgery)
Population a 
million
Aged 0-14 years 
at surgery
Aged 15-18 years 
at surgery
Aged 19+ years 
at surgery Total
0-14 years at 
exposure 11.1 453 496 4095 5044
6 regions 2.2 275 244 1664 2183
21 regions 8.9 178 252 2431 2861
15-18 years at 
exposure 2.2 - 31 1611 1642
6 regions 0.4 - 5 559 564
21 regions 1.8 - 26 1052 1078
Subjects 
exposed in utero 0.5 13 27 72 112
6 regions 0.1 5 11 28 44
21 regions 0.4 8 16 44 68
Subjects born in 
1987 and later 12.0
 b 177 183 146 506
6 regions 2.5 b 57 58 43 158
21 regions 9.5 b 120 125 103 348
Total 
cases 643 737 5924 7304
a - exposed population on 1 January 1987; b - estimation of unexposed population on 1 January 2011 
In this work, the period of study is 1986-2010. The annual dynamics of cases and disease 
incidence are shown in Tables 3.3 and 3.4, respectively. In the analysis of time trends, 
the two-year intervals are used. Also, periods under comparison are subdivided into five 
intervals: 1986-1989 – the period shorter than the minimal duration of latency of radiation-
induced thyroid cancer [4,47] when only sporadic thyroid cancers were diagnosed, and four 
subsequent intervals (1990-1994, 1995-1999, 2000-2004, 2005-2010) when both sporadic 
and radiogenic thyroid cancers are diagnosed in the population. 
Analysis of thyroid cancer incidence in 1986-2010 according to the data 
of Clinico-morphological Registry 
Tables 3.1 and 3.2 summarize data on thyroid cancer in the defined groups, and show 
population size in the 6 and 21 regions. Table 3.1 shows the number of cases for the five 
study periods. Table 3.2 shows the distribution of cases by age at diagnosis, depicting 
cancers diagnosed in childhood, adolescence, and adulthood.
Thus, the current analysis involves 6,798 cases in the exposed population, including 
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5,044 exposed as children, 1,642 cases in irradiated adolescents, and 112 cases of prenatal 
exposure. In subjects born after Chernobyl, i.e. in the unexposed population, 506 cases 
were diagnosed. 
Detailed data on the number of cases, overall incidence for the whole of Ukraine, and for 
the 6 contaminated regions and 21 control regions are presented in Tables 3.3-3.7. 
Data analysis for the groups by age at exposure takes into account that in every calendar 
year we are dealing with a virtual cohort with fixed characteristics of exposure that lived 
certain period after exposure. Thus, for a selected population group, over time, from year 
to year, the parameters of attained age change (increase) (minimum, maximum, median), 
as well as does the time after exposure. Attained age significantly affects the sporadic 
and radiogenic risks; time elapsed after exposure can also be an important parameter for 
calculating radiogenic risk. The attained age and time after exposure uniquely determine 
the age at exposure. 
Detailed data on thyroid cancer cases and trends in the incidence among those exposed 
as children are shown in Table 3.3 and Figure 3.1. During the study period (1986-2010) in 
this group, the age varied from 0 to 14 years old in 1986 and from 24 to 38 years old in 
2010. Table 3.3 shows the cases for the whole of Ukraine, as well as for 6 and 21 regions. 
Population size of this group was estimated to be 11.1 million persons at the beginning of 
1987. This group showed the maximal number of cases (5,044) with about 43% of these 
(2,183 cases) registered in the 6 most contaminated regions. A significant increase in the 
incidence was observed in the first postlatent period (1990-1994) and continued until the 
end of the study (2010). Ascending trends are common to all four groups represented in 
Fig. 3.1 (males in 6 regions, females in 6 regions, males in 21 regions, females in 21 regions), 
although the growth rate and incidences are different for each group. For the low-dose 
regions, the increasing incidence is largely determined by the attained age; in the high-
dose regions, there is an additional influence of radiogenic component and of the factor 
of intensive screening. The maximal  incidence is expectedly observed in females from 
6 contaminated areas (about 15 cases per 100,000 person-years). Incidence rates in the 
most contaminated areas are significantly higher than those in low-contaminated regions, 
although their ratio tends to be lower.
Rates in individuals exposed in adolescence are presented in Table 3.4 and Figure 3.2. 
The population size of this group was 2.2 million. In 2010, the age of this group reached 39-
42 years old. The cumulative number of cases is 1,642, of which 564 (34%) were diagnosed 
in 6 regions with maximal thyroid doses. The main trends of incidence for males and 
females, in general, are similar to those in exposed during childhood. Due to differences 
in median attained age (about 9 years), the absolute values  of the incidence for all four 
categories (males in 6 regions, females in 6 regions, males in 21 regions, and females in 
21 regions) are somewhat higher than the corresponding values in exposed at childhood 
age. The incidence in females from 6 most contaminated regions reached 16-18 cases per 
100,000 person-years at the end of the study period. 
 Figure 3.3 demonstrates incidence trends for those exposed at the age from 0 to 18 
years old for different periods of study. Areas with the highest incidence (Kyiv, Chernihiv, 
Zhytomyr, and Kyiv-City) are located around the Chernobyl Nuclear Power Plant. Of note, 
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there was a pronounced increase in the incidence in this group in low-contaminated regions 
during the last time period (2005-2010). Figure 3.4 presents ranked values  of cumulative 
incidence [55] for those exposed at the age 0-18 years in postlatent period (1990-2010). 
High-dose regions, except for Rivne, demonstrate a value above the average for Ukraine. 
Also, an increased incidence was noted in Kherson and Vinnitsa regions. It should be 
mentioned that a number of studies [56-59] found Polisya (Rivne, Volyn, Zhytomyr regions) 
to be an area with low incidence of sporadic thyroid cancer. The contribution of radiogenic 
cancers led to the increase in incidence in this region, but the values were found to be 
slightly below the average for Ukraine (Rivne region) or below the extreme values for  Kyiv 
and Chernihiv regions (Zhytomyr region). The increased incidence in the industrial regions 
of Ukraine (Kherson, Dnipropetrovsk, and Zaporizhya regions) was mostly observed in 
2000-2010, and does not seem to be associated with radiation factor. 
An estimate of the proportion of cases due to radiation among the total number of 
cases in the study population is of particular interest. Since thyroid cancers induced by 
radiation do not have definite markers and cannot be isolated from the whole group, the 
estimate can only be obtained within a particular statistical model describing the dynamics 
of the disease depending on exposure doses (risk assessment model). So, the proportion 
of radiogenic cancers for the Ukrainian population aged from 0 to 18 years at the time of 
accident and for the study period 1990-1997 was estimated to be 30% [56]. A comparative 
analysis at the level of regions of the country for the period of 1990-2001 [59] resulted 
in an estimate of the proportion of thyroid cancers attributable to Chernobyl radiation of 
30% for the whole population of Ukraine and about 50% for the residents of the 3 most 
contaminated areas (Kyiv, Zhytomyr, and Chernihiv regions). Similar analysis performed in 
the individual cohort study for the residents (at the time of accident) of the 8 radiation-
contaminated areas adjacent to the Chernobyl Nuclear Power Plant, yielded an estimate 
of excess cancer cases diagnosed during 1998-2000 of about 80% [60], and for the cases 
operated in 2001-2007 from 50 to 60% [61].
For individuals exposed in utero, data are presented in Tables 3.1, 3.2, and Figure 3.5. 
The population size of this group was estimated to be 0.52 million people. The number 
of diagnosed cases is 112. For the purpose of easier interpretation of data, Figure 3.5 also 
shows incidence trends for the cohort exposed at the age of 0-4 years old, and for the cohort 
of unexposed subjects born in 1987-1989 which could be considered a rough estimate of 
sporadic thyroid cancer incidence. The in utero group displayed an extremely low incidence 
for the period 1990-1999. During 2000-2010, however, the incidence increased sharply and 
reached values characteristic to the exposed subjects aged 0 to 4 years. If the increase 
in incidence in the in utero group was of radiogenic nature, it should be noted that the 
period of latency was substantially longer. Excess incidence for the in utero group was 
largely observed in the 6 contaminated regions where 44 cases were diagnosed (39%). 
Recently started, a study of radiation effects from in utero exposure is now actively carried 
out [48,49] in the framework of prospective observations. Since the number of cases of 
thyroid cancer registered in these studies so far is very low (<10), it would be promising to 
analyze the risks for this group in well-designed analytical ecologic or case-control studies 




Thyroid cancer cases and incidence per 100,000 childhood population in 1986 (0-14 years old at exposure) 
  1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Cases (F) 4 7 8 22 29 31 64 59 82 92 108 108 143 170 145 214 213 180 228 241 308 331 386 407 446
Cases (M) 4 3 4 7 17 16 27 31 27 33 43 33 41 56 39 55 51 52 44 60 65 69 74 72 95
Cases (Both) 8 10 12 29 46 47 91 90 109 125 151 141 184 226 184 269 264 232 272 301 373 400 460 479 541
Incidence 0.1 0.1 0.1 0.3 0.4 0.4 0.8 0.8 1.0 1.1 1.4 1.3 1.7 2.0 1.7 2.4 2.4 2.1 2.5 2.7 3.4 3.6 4.1 4.3 4.9
6 regions, 
Cases (Both) 3 0 3 9 18 24 49 45 55 61 72 58 85 108 98 131 129 103 113 121 157 165 173 198 205
21 regions,
Cases (Both) 5 10 9 20 28 23 42 45 54 64 79 83 99 118 86 138 135 129 159 180 216 235 287 281 336
6 regions, 
Incidence 0.1 0.0 0.1 0.4 0.9 1.1 2.3 2.1 2.6 2.9 3.4 2.8 4.0 5.1 4.7 6.2 6.1 4.9 5.4 5.8 7.5 7.9 8.2 9.4 9.8
21 regions, 
Incidence 0.1 0.1 0.1 0.2 0.3 0.3 0.5 0.5 0.6 0.7 0.9 0.9 1.1 1.3 1.0 1.5 1.5 1.4 1.8 2.0 2.4 2.6 3.2 3.1 3.7
Table 3.4
Thyroid cancer cases and incidence per 100,000 adolescent population in 1986 (15-18 years old at exposure) 
  1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Cases (F) 8 9 8 6 18 17 23 37 36 54 37 48 59 54 57 70 64 72 79 95 86 95 114 111 106
Cases (M) 3 5 2 4 2 5 8 7 9 6 8 8 9 8 11 14 24 13 7 13 18 21 19 23 32
Cases (Both) 11 14 10 10 20 22 31 44 45 60 45 56 68 62 68 84 88 85 86 108 104 116 133 134 138
Incidence 0.5 0.6 0.4 0.4 0.9 1.0 1.4 2.0 2.0 2.7 2.0 2.5 3.0 2.8 3.0 3.8 3.9 3.8 3.9 4.8 4.7 5.2 6.0 6.0 6.2
6 regions. 
Cases (Both) 1 5 0 3 5 8 7 10 11 20 13 15 26 15 26 31 34 35 30 40 45 46 50 44 44
21 regions,
Cases (Both) 10 9 10 7 15 14 24 34 34 40 32 41 42 47 42 53 54 50 56 68 59 70 83 90 94
6 regions, 
Incidence 0.2 1.1 0.0 0.7 1.1 1.8 1.6 2.3 2.5 4.5 2.9 3.4 5.9 3.4 5.9 7.0 7.7 7.9 6.8 9.1 10.2 10.4 11.3 10.0 10.0
21 regions, 
Incidence 0.6 0.5 0.6 0.4 0.8 0.8 1.3 1.9 1.9 2.2 1.8 2.3 2.3 2.6 2.3 3.0 3.0 2.8 3.1 3.8 3.3 3.9 4.6 5.0 5.2
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Figure 3.1. Time trends of thyroid cancer incidence in 6 and 21 regions of Ukraine for cohort 
aged 0-14 years at exposure. AE – age at exposure; 6R – 6 northern regions; 21R – other 21 regions; 
F – female; M – male. 
Importantly, the interpretation of the number of cases and incidence in the groups 
defined by age at diagnosis (at surgery) should take into account that the composition 
of such groups changes from year to year as the cohorts become older. Both the size of 
the population and the proportion of exposed and unexposed subjects in the group are 
changing. 
Figure 3.2. Time trends of thyroid cancer incidence in 6 and 21 regions of Ukraine for cohort 
aged 15-18 years at exposure. AE – age at exposure; 6R – 6 northern regions; 21R – other 21 regions; 




Thyroid cancer cases and incidence per 100,000 childhood population (0-14 years old at surgery:  
born before 1987, and in 1987 and later) 
  1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Born before 1987
Cases (F) 4 7 7 7 17 15 35 28 30 35 35 29 31 15 10 0 - - - - - - - - -
Cases (M) 4 2 3 4 13 8 19 20 20 14 20 7 11 8 6 2 - - - - - - - - -
Cases 
(Both) 8 9 10 11 30 23 54 48 50 49 55 36 42 23 16 2 - - - - - - - - -
Incidence 0.1 0.1 0.1 0.1 0.4 0.3 0.8 0.8 1.0 1.1 1.4 1.2 1.8 1.5 2.1 0.7 - - - - - - - - -
6 regions, 
cases (Both) 3 0 3 4 12 15 37 31 31 34 37 25 26 14 7 1
21 regions, 
cases (Both) 5 9 7 7 18 8 17 17 19 15 18 11 16 9 9 1
6 regions, 
incidence 0.1 0.0 0.2 0.2 0.7 1.0 2.8 2.6 3.0 3.8 4.9 4.1 5.7 4.6 4.6 2.0 - - - - - - - - -
21 regions, 
Incidence 0.1 0.1 0.1 0.1 0.3 0.1 0.3 0.3 0.4 0.4 0.6 0.4 0.9 0.7 1.5 0.5 - - - - - - - - -
Born in 1987 and in subsequent years
Cases (F) - - - - - - - - - 1 0 1 1 2 10 8 19 7 6 18 7 14 8 11 18
Cases (M) - - - - - - - - - 0 2 0 1 3 3 7 6 2 3 3 1 3 2 5 5
Cases 
(Both) - - - - - - - - - 1 2 1 2 5 13 15 25 9 9 21 8 17 10 16 23
Incidence - - - - - - - - - 0.02 0.03 0.02 0.03 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.3 0.2 0.2 0.4
6 regions, 
cases (Both) - - - - - - - - - - - 1 - 2 2 6 11 3 2 4 3 5 2 7 9
21 regions, 
cases (Both) - - - - - - - - - 1 2 - 2 3 11 9 14 6 7 17 5 12 8 9 14
6 regions, 
Incidence - - - - - - - - - - - 0.08 - 0.1 0.1 0.4 0.7 0.2 0.1 0.3 0.2 0.4 0.2 0.5 0.7
21 regions, 
Incidence - - - - - - - - - 0.02 0.04 - 0.04 0.1 0.2 0.1 0.2 0.1 0.1 0.3 0.1 0.2 0.2 0.2 0.3
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Table 3.6
Thyroid cancer cases and incidence per 100,000 adolescent population (15-18 years old at surgery:  
born before 1987, and in 1987 and later)
  1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Born before 1987
Cases (F) 1 4 0 5 6 7 7 9 19 8 15 12 18 29 30 32 29 20 5 4 - - - - -
Cases (M) 10 9 8 15 9 13 17 13 11 20 23 11 24 31 10 21 19 14 13 3 - - - - -
Cases (Both) 11 13 8 20 15 20 24 22 30 28 38 23 42 60 40 53 48 34 18 7 - - - - -
Incidence 0.4 0.5 0.3 0.7 0.5 0.7 0.8 0.8 1.0 1.0 1.3 0.8 1.4 2.0 1.3 1.7 2.1 2.2 2.3 2.8 - - - - -
6 regions, 
cases (Both) 1 4 0 5 6 7 7 9 19 8 15 12 18 29 30 32 29 20 5 4 - - - - -
21 regions, 
cases (Both) 10 9 8 15 9 13 17 13 11 20 23 11 24 31 10 21 19 14 13 3 - - - - -
6 regions, 
incidence 0.2 0.7 0.0 0.9 1.0 1.2 1.2 1.6 3.3 1.4 2.6 2.1 3.1 4.8 4.9 5.2 6.29 6.5 3.3 8.2 - - - - -
21 regions, 
incidence 0.5 0.4 0.3 0.6 0.4 0.6 0.7 0.6 0.5 0.9 1.0 0.5 1.0 1.3 0.4 0.9 0.8 1.1 2.1 1.4 - - - - -
Born in 1987 and in subsequent years
Cases (F) - - - - - - - - - - - - - - - - 1 4 3 9 9 7 5 13 7
Cases (M) - - - - - - - - - - - - - - - - 3 7 14 22 19 14 16 15 15
Cases (Both) - - - - - - - - - - - - - - - - 4 11 17 31 28 21 21 28 22
Incidence - - - - - - - - - - - - - - - - 0.5 0.7 1.0 1.4 1.1 0.8 0.9 1.3 1.1
6 regions, 
cases (Both) - - - - - - - - - - - - - - - - 1 4 3 9 9 7 5 13 7
21 regions. 
cases (Both) - - - - - - - - - - - - - - - - 3 7 14 22 19 14 16 15 15
6 regions, 
incidence - - - - - - - - - - - - - - - - 0.7 1.3 0.7 1.7 1.7 1.4 1.0 2.9 1.6
21 regions, 
incidence - - - - - - - - - - - - - - - - 0.5 0.6 0.8 1.1 0.9 0.7 0.8 0.8 0.9
52
Chapter 3
Figure 3.3. Region (oblast) specific time trends of thyroid cancer incidence in the cohort aged 
0-18 years at exposure, both sexes.
Table 3.5 and Figure 3.6 demonstrate the statistics of cases and incidence trends for 
the age group 0-14 years at diagnosis. The incidence in this group was approximately 0.1 
case per 100,000 person-years of childhood population during the period of latency (1986-
1989), and then displayed a sharp increase already noticeable in the early postlatent period 
(1990-1992). Incidence in females from the 6 most contaminated regions increased in 1992-
1998 more than 20-fold as compared to the period of latency. The increased incidence in 
females and males from the 6 regions started to decline synchronously after 1998, with 
transition of the most exposed group (aged 0-4 years at the time of the accident) to older 
age categories. 
Since 2001, this group does not include exposed subjects (even those potentially 
irradiated in utero) any more. Incidences in males from the 6 and 21 regions are not 
significantly different, while that in females from the 6 most contaminated regions is 
approximately 2-fold higher than in less contaminated regions. Incidence rate for the group 
aged 0-14 years is widely used in cancer statistics, and the observed values (0.2-0.4 cases 
per 100,000 person-years) for unexposed Ukrainian population can be compared with data 
from other countries and other registries. Such a comparison with the ranked data from 28 
European countries [11] suggests that the incidence in Ukraine for the group 0-14 years in 
the period 2003-2010 was about the European average. 
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Figure 3.4. Ranking plot of region (oblast) specific cumulative incidence x 100 000 in 1990-2010 
for the cohort aged 0-18 years at exposure, both sexes.
 
In the age group of 15-18 years old at diagnosis, the increasing incidence in the 6 high-
dose regions was more gradual compared to the childhood group and reached maximal 
values  both in females and males in 1998-2002 (Table 3.6 and Figure 3.7). Exposed 
population was not in the group since 2006, after which the incidence in males and females 
in the 6 and 21 regions became closer. 
In the age group of 19+ years old at diagnosis, incidence trends were markedly different 
from the younger groups (Figure 3.8). This group has no upper age limit, and its size, median 
age, and age structure change every year. Incidence rates in the four categories (males in 
6 regions, females in 6 regions, males in 21 regions, females in 21 regions) show increasing 
trends. The maximal rates were observed in females from the 6 most contaminated regions, 
followed by that in females from 21 regions, then in males from the 6 regions and the 
minimal was in males from 21 regions. It should be noted that in the “adult cohort”, the 




Thyroid cancer cases and incidence per 100,000 in subjects aged 19+ years at surgery (born before and after Chernobyl) 
  1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010
Born before 1987
Cases (F) 0 2 3 4 19 19 33 54 65 91 83 113 148 166 165 253 246 233 300 338 400 431 511 531 570
Cases (M) 0 0 1 4 2 7 12 12 9 17 21 26 22 40 34 53 59 54 50 73 85 92 96 100 131
Cases 
(Both) 0 2 4 8 21 26 45 66 74 108 104 139 170 206 199 306 305 287 350 411 485 523 607 631 701
Incidence - 0.6 0.4 0.5 0.9 0.8 1.2 1.4 1.5 1.8 1.5 1.9 2.1 2.3 2.1 2.9 2.7 2.4 2.8 3.0 3.7 3.9 4.5 4.7 5.2
6 regions, 
cases (Both) - 1 0 3 5 10 13 15 16 39 33 37 68 80 88 133 134 119 141 161 208 213 229 249 256
21 regions, 
cases (Both) - 1 4 5 16 16 32 51 58 69 71 102 102 126 111 173 171 168 209 250 277 310 378 382 445
6 regions, 
incidence - 1.5 - 0.9 1.1 1.6 1.7 1.6 1.5 3.2 2.4 2.5 4.1 4.5 4.5 6.4 6.0 5.0 5.5 6.0 7.8 8.0 8.5 9.2 9.5
21 regions, 
incidence - 0.4 0.5 0.4 0.9 0.7 1.0 1.4 1.4 1.4 1.3 1.7 1.6 1.8 1.4 2.1 1.9 1.8 2.1 2.4 2.6 2.9 3.5 3.6 4.1
Born in 1987 and in subsequent years
Cases (F) - - - - - - - - - - - - - - - - - - - - 6 7 20 38 49
Cases (M) - - - - - - - - - - - - - - - - - - - - 1 2 5 8 10
Cases 
(Both) - - - - - - - - - - - - - - - - - - - - 7 9 25 46 59
Incidence - - - - - - - - - - - - - - - - - - - - 0.7 0.5 1.1 1.6 1.7
6 regions, 
cases (Both) - - - - - - - - - - - - - - - - - - - - 3 2 9 14 15
21 regions, 
cases (Both) - - - - - - - - - - - - - - - - - - - - 4 7 16 32 44
6 regions, 
incidence - - - - - - - - - - - - - - - - - - - - 1.5 0.6 1.9 2.4 2.1
21 regions, 
incidence - - - - - - - - - - - - - - - - - - - - 0.5 0.5 0.9 1.4 1.6
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Figure 3.5. Thyroid cancer incidence in 3 birth cohorts, both sexes: aged 0-4 years at exposure 
(ATA – age at exposure; B – both sexes); exposed in utero (EIU – exposed in utero, Ukraine – whole 
Ukraine, B – both sexes); born in 1987-1989 (BY – year of birthday; Ukraine – whole Ukraine, B – both 
sexes). 
Figure 3.6. Time trends of thyroid cancer incidence among children aged 0-14 years at surgery. 
AS – age at surgery; 6R – 6 northern regions of Ukraine; 21R – other 21 regions of Ukraine; F – female; 
M – male. 
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Figure 3.7. Time trends of thyroid cancer incidence among adolescents aged 15-18 years at 
surgery. AS – age at surgery; 6R – 6 northern regions of Ukraine; 21R – other 21 regions of Ukraine; 
F – female; M – male. 
Figure 3.8. Time trends of thyroid cancer incidence among adults aged 19+ years at surgery. AS 
– age at surgery; 6R – 6 northern regions of Ukraine; 21R – other 21 regions of Ukraine; F – female; 
M – male. 
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Figure 3.9. Time trends of thyroid cancer incidence in 21 less contaminated regions of Ukraine 
among 3 exposed and 1 unexposed birth cohorts. AE – age at exposure; 6R - 6 northern regions of 
Ukraine; B – both sexes; BY – year of birthday; Ukraine – whole Ukraine. 
As the next step, we consider in a descriptive analysis the birth cohort effect for exposed 
and unexposed populations by comparing the incidence trends in the three exposed 
cohorts (0-4, 5-9, and 10-14 years old at the time of exposure), and in the unexposed cohort 
(nearest by age to the exposed cohorts) born in 1987-1989. Time trends are considered 
separately for the 6 regions and 21 regions without subdivision by sex. The size of cohorts 
(0-4, 5-9, and 10-14 years old at exposure) were 0.75, 0.71 and 0.73 million for high-dose 
regions, respectively, and about 3 million in each age group for the 21 low-dose regions. 
The size of the unexposed cohort born in 1987-1989 for the whole of Ukraine was about 
2.2 million. 
Figure 3.9 presents incidence trends in the postlatent period for these four cohorts in 
the 21 low-dose regions. At the beginning of the study period (1990-1992), the incidence 
in each cohort did not exceed 0.5 case per 100,000 person-years. In subsequent years, the 
cohorts showed a gradual growth of incidence, and at the end of the study incidence rates 
ranged from 2.2 to 4.1 cases per 100,000 person-years. It is noteworthy that during the 
analyzed period of time the incidences displayed a strictly ordered character according 
to attained age. For each fixed period, the cohort born in 1987-1989 showed the lowest 
incidence; the next higher value of incidence was observed in the cohort aged 0-4 years at 
exposure (the difference in the attained age with the previous cohort was about 4 years); 
then in the cohort aged 5-9 years at exposure, and the maximal value was in the cohort 
of 10-14 years at exposure. The shapes of trends for all cohorts are similar and close to the 
exponential curves. 
Figure 3.10 presents incidence trends in postlatent period for similar four cohorts in the 
6 high-dose regions. The trend in the cohort of subjects born in 1987-1989 is the same as in 
Fig. 3.9, and exponentially increases from 0 to 2.2 cases per 100,000 person-years. 
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Figure 3.10. Time trends of thyroid cancer incidence in 6 northern regions of Ukraine among 3 
exposed, and 1 unexposed birth cohorts. AE – age at exposure; 6R - 6 northern regions of Ukraine; 
B – both sexes; BY – birtnday year; Ukraine – whole Ukraine. 
In the exposed cohorts, the sporadic incidence is supplemented by the radiogenic 
component and possibly by the factor of screening [58,62]. The trends in the exposed 
cohort are less “smooth”, the values vary within the wide range  (from 1 to 10.5 cases per 
100,000 person-years) and do not show the “natural” ordering by attained age. Moreover, in 
the period of 1990-1998, the highest incidence was observed in the youngest cohort of 0-4 
years old at exposure, which had accumulated maximal thyroid doses. From 1998 to 2006, 
the incidence in this cohort was almost stable: about 5 cases per 100,000 person-years, 
after which it continued to increase. 
In the cohort aged 5-9 years old at exposure the incidence began to grow as rapidly 
as in the younger cohort in 1990, but until 2004 it was lower. The incidence in the older 
age group (10-14 years old at exposure) was slowly increasing until 1996, after which the 
growth accelerated and, beginning from 2000, it occupied a “natural” position with the 
highest incidence rate. 
At the end of the study period (2010), the rate ratios in the groups of 0-4, 5-9, and 10-14 
years old at exposure for 21 regions to the cohort born in 1987-1989 were 1.4, 1.7, and 1.9 
(Fig. 3.9), respectively. The ratios for the 6 high-dose regions are remarkably higher: 3.3, 4.7, 
and 4.8, respectively. 
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Thyroid cancer incidence at the level of the whole population according to the data 
of National Cancer Registry 
Finally, we will briefly discuss the incidence and mortality rates for the whole population 
of Ukraine in the period 1999-2010 according to the National Cancer Registry data [13]. 
During this period of time, the number of newly reported cases of thyroid cancer increased 
steadily from 2,093 (360 males and 1,733 females) cases in 2001 to 2,869 (508 males and 
2,361females) in 2010. The annual increase in the incidence was 77.6 cases; it was faster in 
females (62.8 cases) compared to 14.8 cases in males. The sex ratio (the ratio of the number 
of cases in females to the number of cases in males) was 4.7 on average for the period 2001-
2010 ranging from 4.2 to 5.3. 
Figures 3.11 and 3.12 represent the trends of thyroid cancer incidence and mortality, 
respectively, due to thyroid cancer for the whole population of Ukraine for the period 1999-
2010 according to the NCR [13]. During this period, the incidence showed an ascending 
trend both in females (from 6.5 to about 9 cases per 100,000) and males (from 1.9 to 2.5 
cases per 100,000). At the same time, mortality rates vary within the ranges 1-1.2 per 
100,000 in females and 0.5-0.6 in 100,000 in males with a tendency to a slow decrease. A 
similar relationship between the incidence and mortality is typical for the registries of other 
countries [1,8,9]. Such a ratio (declining trend of mortality and increasing incidence) reflects 
the fact that the increase in incidence is largely due to the growing number of curable well-
differentiated tumors, and also due to improvements in the quality of diagnosis over time. 
Figure 3.11. Age-adjusted incidence rates of thyroid cancer per 100,000 general population of 
Ukraine in 2000-2010. Data from ref. [13]. 
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Figure 3.12. Age-adjusted mortality rates of thyroid cancer per 100,000 general population of 
Ukraine in 2000-2010. Data from ref. [13]. 
In summary, this chapter demonstrates that among the exposed population of children 
and adolescents (aged 0-18 years at the time of accident), there has been a significant 
increase in thyroid cancer incidence after the minimal period of latency; this tendency 
persists for the period of 20 years (1990-2010). At the same time, incidence rate in the 6 
most contaminated regions exceeded that in 21 low-contaminated regions for all postlatent 
periods of study. However, in both high- and low-contaminated regions, incidence rate 
displays a descending tendency, perhaps indicating a gradual decrease in the contribution 
of radiation factor in the increased thyroid cancer incidence in the cohort aged 0-18 years 
at the time of Chernobyl accident. Among those exposed in utero, a significant growth of 
incidence started after 15 years since accident and continued to grow during the further 
period. 
By age at diagnosis, peak incidences in childhood and adolescent groups were observed 
in 1995-1997 and 2000-2002, respectively. Since 2002 there are no exposed subjects 
(including the in utero cohort) in the childhood group and since 2006 in the adolescent 
group. Thus, in these age categories all childhood and adolescent cases of radiogenic 
thyroid cancer have been realized. In the corresponding groups of unexposed subjects 
aged 0-14 and 15-18 years at the time of diagnosis, thyroid cancer incidence is comparable 
to the average rate in European countries.
Incidence of sporadic thyroid cancer markedly increases from the age of 25-30 years old; it 
may, therefore, be expected that the proportion of radiogenic cancers in Ukraine will decline, 
even in the regions with relatively high levels of radiation exposure. On the other hand, as 
shown in a recent study [63], a statistically significant contribution of radioinduced thyroid 
cancers developing after acute external irradiation can be observed even 50-60 years after 
exposure. This fact justifies the need for continuous monitoring and analysis of the incidence 
of thyroid cancer in the population groups exposed as a result of Chernobyl catastrophe. 
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